dr thorvardur halfdanarson discusses lack of risk factors, biomarkers in nets
Published 5 years ago • 124 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
2:00
dr thorvardur halfdanarson on diagnostics in nets
-
1:32
dr thorvardur halfdanarson discusses if he thinks there's a future for immunotherapy in nets
-
20:08
what's new in nets: medical (thor halfdanarson, md)
-
14:53
net 2017 thorvadur halfdanarson m d
-
1:00:23
live with dr. thorvardur (thor) halfdanarson!
-
57:25
transfusion decisions
-
26:57
nets overview thor halfdanarson, md mayo clinic
-
18:16
surgery for neuroendocrine tumors
-
18:01
medical management of nets: targeted therapy by dr. thor halfdanarson
-
49:07
know your nets treatment sequencing tumor board
-
1:30:15
lacnets webinar: "2022: year in review" with medical oncologist dr. thor halfdanarson
-
1:24
anwar khursid, m.d., medical oncology, hematology
-
1:03
dr. halfdanarson on net awareness
-
1:35
meet urologist seth a. cohen, m.d. | city of hope
-
1:06
shatha farhan, md - medical oncology & hematology, henry ford health system
-
20:03
45 years of the mslt: where are we now? - season three - episode 1
-
3:11
which research made "best of ash" in 2017?
-
21:09
08 - cumulative treatment toxicities by dr. thor halfdanarson
-
1:29
a case of a surprising metastasis
-
1:47
immunotherapy for multiple myeloma: current research avenues
-
3:25
spore grant awarded to multiple myeloma research team from mayo clinic cancer center